Journal
TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Volume 12, Issue 5, Pages 283-293Publisher
KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
DOI: 10.1007/s13770-015-0014-6
Keywords
Osteomyelitis; Three-dimensional printing technology; Antibiotics; Biodegradable scaffold
Categories
Funding
- National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2010-0018294]
- R&D program of MSIP/COMPA [2014K000163]
- Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI11C0388]
Ask authors/readers for more resources
Osteomyelitis, an infection and inflammation of bone marrow, often progresses to chronic stage because of delay in diagnosis and treatment. Once it becomes chronic, intravenous antibiotics therapy is no longer effective as swollen surrounding tissue interrupts blood flow into the infected tissue. In severe cases, debridement of the necrotic tissue becomes necessary to prevent further infection. In this study, for the first time, we produced three-dimensional (3D) printed antibiotics-loaded biodegradable poly-e-caprolactone/poly(lactic-co-glycolic acid) scaffold for treatment of chronic osteomyelitis. Subsequent bone regeneration in debrided site was also observed with the customized scaffolds fabricated using 3D printing. Tobramycin, one of the most widely used antibiotics in orthopedic surgery, was chosen due to its thermostable nature compliant to the heat-based fabrication conditions. In in vitro tests, antibacterial and anti-inflammatory effects and release profile of tobramycin from the scaffold were evaluated to verify the potential of our scaffold as a drug delivery system. In addition, in vivo efficacy of the developed drug loaded scaffolds for treatment of chronic osteomyelitis was also examined in a rat model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available